National and Kapodistrian University of Athens
Συγκριτική μελέτη του συστήματος των ενδοθηλίνων στον καρκίνο του μαστού
Abstract
dc:descriptionAim: Endothelins are involved in the evolution of multiple malignancies, participating in the proliferation of cancer cells, tumor invasion and neoangiogenesis. In breast cancer, the expression of Endothelin-1 (ET-1) and its receptors has been associated with the transition from benign breast tissue to invasive carcinoma, while the expression of its precursor (Big Endothelin-1, Big ET-1) has been observed to be elevated in patients with invasive breast cancer. The purpose of the present study is to determine the circulating levels and tissue expression of endothelin in patients with benign or malignant breast lesions, and the possible correlation with established neoplasia characteristics.Materials and Methods: 124 women that underwent stereotactic breast biopsy for the assessment of suspicious non-palpable breast lesions, and 30 healthy women who comprised the control group, were included in the study. Circulating levels of ET-1 and Big ET-1 were measured using ELISA, while the expression of ET-1 and VEGF in biopsy tissue samples was assessed using semi-quantitative immunohistochemical staining. The correlation of these results with the clinicopathologic characteristics of the disease was also investigated.Results: The plasma levels of Big ET-1 were found to be significantly increased in patients with IDC and DCIS compared to patients with Proliferative Lesions and controls. There was no significant difference in the plasma or tissue expression of ET-1 between the patient groups. In patients with IDC, plasma expression of ET-1 and Big ET-1 did not correlate with tumor size, tumor grade, ER/PR status, Her2 overexpression, axillary lymph node invasion, TNM stage or tissue ET-1 and VEGF expression. Moreover, in patients with DCIS, plasma expression of ET-1 and Big ET-1 did not correlate with the nuclear grade. Plasma expression of Big ET-1, was significantly elevated in patients with LN compared to controls. However, there was no difference in plasma or tissue expression of ET-1 in these patients.Conclusions: The elevated expression of Big ET-1 in patients with IDC, DCIS and LN confirms the hypothesis of deregulation of the endothelin system in neoplastic lesions of the breast, highlighting the potential use of Big ET-1 as a biomarker of the disease. The clarification of the exact role of the endothelin system in breast cancer might contribute to new diagnostic, prognostic and therapeutic approaches in breast cancer patients.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kalles, Vasileios-Stefanos
- Καλλές, Βασίλειος-Στέφανος
Subjects
dc:subject × 16Rights
dc:rights- Statement dc:rights
-
- BY_NC_SA
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/41472